Hidalgo-Simon A - Search Results

1

Evaluation of the effectiveness of risk minimization measures.

Prieto L, Spooner A, Hidalgo-Simon A, Rubino A, Kurz X, Arlett P. Prieto L, et al. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):896-9. doi: 10.1002/pds.3305. Epub 2012 Jun 22. Pharmacoepidemiol Drug Saf. 2012. PMID: 22730332 No abstract available.

2

Pharmacovigilance in Europe: direction of travel in a changing environment.

Hidalgo-Simon A, Arlett P. Hidalgo-Simon A, et al. Expert Rev Clin Pharmacol. 2012 Sep;5(5):485-8. doi: 10.1586/ecp.12.46. Expert Rev Clin Pharmacol. 2012. PMID: 23121266 No abstract available.

3

Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.

Kurz X, Domergue F, Slattery J, Segec A, Szmigiel A, Hidalgo-Simon A. Kurz X, et al. Vaccine. 2011 Jun 10;29(26):4378-87. doi: 10.1016/j.vaccine.2011.04.005. Epub 2011 Apr 16. Vaccine. 2011. PMID: 21501644

4

Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.

Isai A, Durand J, Le Meur S, Hidalgo-Simon A, Kurz X. Isai A, et al. Vaccine. 2012 Nov 19;30(49):7123-9. doi: 10.1016/j.vaccine.2012.09.032. Epub 2012 Sep 26. Vaccine. 2012. PMID: 23022149 Review.

5

Drug-induced PML: a global agenda for a global challenge.

Vinhas de Souza M, Keller-Stanislawski B, Blake K, Hidalgo-Simon A, Arlett P, Dal Pan G. Vinhas de Souza M, et al. Clin Pharmacol Ther. 2012 Apr;91(4):747-50. doi: 10.1038/clpt.2012.4. Epub 2012 Feb 29. Clin Pharmacol Ther. 2012. PMID: 22378158

6

Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.

Eichler HG, Pignatti F, Schwarzer-Daum B, Hidalgo-Simon A, Eichler I, Arlett P, Humphreys A, Vamvakas S, Brun N, Rasi G. Eichler HG, et al. Among authors: hidalgo simon a. Clin Pharmacol Ther. 2021 May;109(5):1212-1218. doi: 10.1002/cpt.2083. Epub 2020 Nov 12. Clin Pharmacol Ther. 2021. PMID: 33063841 Free PMC article. Review.

7

Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.

Segec A, Keller-Stanislawski B, Vermeer NS, Macchiarulo C, Straus SM, Hidalgo-Simon A, De Bruin ML. Segec A, et al. Among authors: hidalgo simon a. Clin Pharmacol Ther. 2015 Nov;98(5):502-5. doi: 10.1002/cpt.199. Epub 2015 Sep 11. Clin Pharmacol Ther. 2015. PMID: 26250806 Review.

8

Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab.

Vermeer NS, Straus SM, Mantel-Teeuwisse AK, Hidalgo-Simon A, Egberts AC, Leufkens HG, De Bruin ML. Vermeer NS, et al. Among authors: hidalgo simon a. Clin Pharmacol Ther. 2015 Nov;98(5):542-50. doi: 10.1002/cpt.207. Epub 2015 Sep 8. Clin Pharmacol Ther. 2015. PMID: 26347128

9

Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.

Blake KV, Zaccaria C, Domergue F, La Mache E, Saint-Raymond A, Hidalgo-Simon A. Blake KV, et al. Paediatr Drugs. 2014 Aug;16(4):309-19. doi: 10.1007/s40272-014-0076-2. Paediatr Drugs. 2014. PMID: 24898717

10

Identifiability of Biologicals in Adverse Drug Reaction Reports Received From European Clinical Practice.

Vermeer NS, Giezen TJ, Zastavnik S, Wolff-Holz E, Hidalgo-Simon A. Vermeer NS, et al. Among authors: hidalgo simon a. Clin Pharmacol Ther. 2019 Apr;105(4):962-969. doi: 10.1002/cpt.1310. Epub 2019 Jan 11. Clin Pharmacol Ther. 2019. PMID: 30460997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters